Clinical Trials in San Francisco

Showing 2881-2900 of 6,211 trials

Intensive Consolidation and Stem Cell Mobilization Therapy Followed by Autologous Stem Cell Transplantation in High-risk Patients With Relapsed/Refractory Diffuse Large B-Cell Lymphoma

NCT01555541

The goal of this clinical trial is to show that incorporating ofatumumab instead of rituximab in combination with etoposide and cytarabine (OVA) is successful in collecting autologous stem cells for use in an autologous stem cell transplantation (autoSCT) and to examine its effectiveness in eliminating residual diffuse large B-Cell Lymphoma (DLBCL) in patients.

Diffuse Large Cell Lymphoma Relapsed/Refractory

C. Babis Andreadis19 participantsStarted May 2012

San Francisco, California, United States

COMPLETEDNA< 1 mile

Thoratec HeartMate II Left Ventricular Assist System (LVAS) for Bridge to Cardiac Transplantation

NCT00121472

The purpose of this study is to determine the safety and effectiveness of the Thoratec HeartMate II Left Ventricular Assist System (LVAS) as a bridge to cardiac transplantation in end-stage heart failure patients who are listed for cardiac transplant but are at imminent risk of dying. The HeartMate II LVAS was approved by the US FDA on April 21, 2008, as a bridge to cardiac transplantation (reference PMA P060040). It was approved for commercial distribution in Canada on May 20, 2009 (reference Medical Device Licence #79765). Patients enrolled into the clinical trial will continue to be followed until all have reached a clinical outcome.

Heart Failure, CongestiveVentricular DysfunctionCardiomyopathies

Abbott Medical Devices194 participantsStarted Mar 2005

Birmingham, Alabama, United States • Phoenix, Arizona, United States • San Diego, California, United States +33 more locations

Intensive Consolidation and Stem Cell Mobilization Therapy Followed by Autologous Stem Cell Transplantation in High-risk Patients With Relapsed/Refractory Diffuse Large B-Cell Lymphoma

Thoratec HeartMate II Left Ventricular Assist System (LVAS) for Bridge to Cardiac Transplantation

Find Trials by Condition in San Francisco

Prevention of Non-Surgical Bleeding by Management of HeartMate II Patients Without Antiplatelet Therapy

Hormone Therapy and Radiation Therapy or Hormone Therapy and Radiation Therapy Followed by Docetaxel and Prednisone in Treating Patients With Localized Prostate Cancer

Study of Aztreonam for Inhalation in Children With Cystic Fibrosis and New Infection of the Airways by Pseudomonas Aeruginosa Bacteria

A Digital Flu Intervention for People With Cardiovascular Conditions

NBA G-League Sweat Testing Study: Validity of the Gx Sweat Patch in Measuring Sweating Rate and Sweat Chloride Concentration During On-court Training With Basketball Players

A Rehabilitation Tool to Determine Patient's Stay in Hospital After Joint Replacement

A Study of Dulaglutide (LY2189265) in Children and Adolescents With Type 2 Diabetes

Surgical Idiopathic Intracranial Hypertension Treatment Trial

Stanford Letter or Traditional Advance Directive in Advance Care Planning in Patients Undergoing Bone Marrow Transplant

Follow-up of the VIPES Study to Evaluate Efficacy and Safety of Viaskin Peanut in Adults and Children

Healing Touch During Chemotherapy Infusions for Women With Breast Cancer

Transrectal Photoacoustic Imaging of the Prostate

Esteem New Subject Enrollment Post Approval Study

Study of Multiple Candidate Agents for the Treatment of COVID-19 in Hospitalized Patients

Efficacy and Safety of Decitabine as Epigenetic Priming With Induction Chemotherapy in Pediatric Acute Myelogenous Leukemia (AML) Subjects

SHIELD II Clinical Investigation

A Study of Two Different Dose Combinations of Nivolumab in Combination With Ipilimumab in Subjects With Previously Untreated, Unresectable or Metastatic Melanoma

Efficacy and Safety Study of Apremilast to Treat Active Psoriatic Arthritis (PsA)